Literature DB >> 2133113

C-MYC: evidence for multiple regulatory functions.

L J Penn1, E M Laufer, H Land.   

Abstract

The nuclear c-myc proto-oncogene promotes cell proliferation and can inhibit terminal differentiation as well as induce immortalisation in its oncogenic form. There is increasing evidence that c-myc exerts these biological activities by modulating transcription and by directly affecting the initiation of DNA replication. The regulation of these disparate activities may involve the carboxyl end of the c-myc protein, which is essential for transformation and autosuppression of c-myc transcription. Conserved motifs in this region of the c-myc protein may mediate complex formation and sequence-specific nucleic acid binding.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2133113

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  23 in total

1.  Analysis of E-box DNA binding during myeloid differentiation reveals complexes that contain Mad but not Max.

Authors:  K M Ryan; G D Birnie
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 2.  Cell cycle and apoptosis.

Authors:  Katrien Vermeulen; Zwi N Berneman; Dirk R Van Bockstaele
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

Review 3.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

4.  Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma.

Authors:  C L Williams; V A Lennon
Journal:  Cell Regul       Date:  1991-05

Review 5.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

6.  Multiple phenotypes associated with Myc-induced transformation of chick embryo fibroblasts can be dissociated by a basic region mutation.

Authors:  D H Crouch; R Gallagher; C R Goding; J C Neil; R Fulton
Journal:  Nucleic Acids Res       Date:  1996-08-15       Impact factor: 16.971

7.  Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers.

Authors:  D L Solomon; B Amati; H Land
Journal:  Nucleic Acids Res       Date:  1993-11-25       Impact factor: 16.971

8.  Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis.

Authors:  Peter J Hurlin; Zi-Qiang Zhou; Kazuhito Toyo-oka; Sara Ota; William L Walker; Shinji Hirotsune; Anthony Wynshaw-Boris
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

Review 9.  Growth hormone signal transduction.

Authors:  P Maharajan; V Maharajan
Journal:  Experientia       Date:  1993-11-15

10.  Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2007-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.